A variety of genetically altered mouse models with perturbed insulin signalling have suggested that disruption of the insulin signalling in the heart causes pathophysiological consequences including decreased contractile function and altered cardiac size either under basal conditions or in the presence of pathological stressors (e.g. myocardial infarction) [120–124]. The gene discussed is INS; the disease is myocardial infarction.